SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease

The anatomic and clinical complexity of patients with coronary artery disease (CAD) is increasing in the United States.1-3 While the terms “complex CAD” or “high-risk CAD” have not been formally defined, they encompass both complex anatomic lesions and clinical parameters including advanced age, frailty, comorbidities, compromised hemodynamic status, depressed ventricular function and concomitant valvular disease.4-6 Such features increase both...